。。。the deal will give Gilead up to $500 million in revenue borne almost entirely by American taxpayers, “in whole or in part” through higher insurance premiums. “Outside analysts have concluded that ‘The deal is amazingly good for Gilead’s executives and shareholders and amazingly bad for everyone else—bad for taxpayers, terrible for public health, and unethical,’” the lawmakers wrote in the later dated Thursday. “We are therefore requesting information from the Department to help us better understand why President Trump—or whichever Administration officials were responsible— would strike such an expensive deal, and what steps the Administration is taking to ensure sufficient supply of the drug.” Gilead and HHS weren’t immediately available for comment. The deal gives the U.S. more than 500,000 treatment courses of the antiviral drug for U.S. hospitals through September, the Department of Health and Human Services announced June 29. That represents 100% of Gilead’s projected production for July and 90% of production for August and September, according to the agency. Gilead said it would sell remdesivir for $520 per vial in the U.S. to patients with private insurance and $390 per vial to federal insurance programs like Medicare as well as foreign countries. The majority of patients treated with remdesivir receive a five-day treatment course using six vials of remdesivir, the company said. That would bring the cost to $2,340 for foreign and U.S. Medicare patients and $3,120 for U.S. patients with private health coverage.
因为价格吧 https://www.vanhollen.senate.gov/news/press-releases/van-hollen-warren-criticize-trump-administration-deal-that-allowed-manufacturer-of-covid-19-antiviral-drug-remdesivir-to-charge-us-purchasers-the-highest-prices-in-the-world Gilead has stated that governments of other developed countries will be paying $2,340 for a treatment course of remdesivir, but that American hospitals and other purchasers will be paying "approximately $3,200" – $860 more than the price in other countries. The higher prices charged by Gilead will result in higher insurance premiums for individuals and businesses that provide health insurance coverage. Although Medicare and Medicaid beneficiaries may be shielded from these higher costs, the costs of the drug will be borne by taxpayers, who will ultimately foot the bill for reimbursement. According to one study, a full course of remdesivir treatment can be manufactured and sold with a 10% profit margin for about $9 – meaning that the price set by Gilead for health insurers is more than 350 times greater than the price necessary to produce and profit from the drug.
“Gilead said it would sell remdesivir for $520 per vial in the U.S. to patients with private insurance and $390 per vial to federal insurance programs like Medicare as well as foreign countries.” 这句话不是质问为什么美国卖到国内的反而比卖到国外的贵么？不是想办法减少美国人民的医疗负担么？
“Gilead said it would sell remdesivir for $520 per vial in the U.S. to patients with private insurance and $390 per vial to federal insurance programs like Medicare as well as foreign countries.” 这句话不是质问为什么美国卖到国内的反而比卖到国外的贵么？不是想办法减少美国人民的医疗负担么？ 梦境行者 发表于 2020-07-17 01:04
“Gilead said it would sell remdesivir for $520 per vial in the U.S. to patients with private insurance and $390 per vial to federal insurance programs like Medicare as well as foreign countries.” 这句话不是质问为什么美国卖到国内的反而比卖到国外的贵么？不是想办法减少美国人民的医疗负担么？ 梦境行者 发表于 2020-07-17 01:04
因为价格吧 https://www.vanhollen.senate.gov/news/press-releases/van-hollen-warren-criticize-trump-administration-deal-that-allowed-manufacturer-of-covid-19-antiviral-drug-remdesivir-to-charge-us-purchasers-the-highest-prices-in-the-world Gilead has stated that governments of other developed countries will be paying $2,340 for a treatment course of remdesivir, but that American hospitals and other purchasers will be paying "approximately $3,200" – $860 more than the price in other countries. The higher prices charged by Gilead will result in higher insurance premiums for individuals and businesses that provide health insurance coverage. Although Medicare and Medicaid beneficiaries may be shielded from these higher costs, the costs of the drug will be borne by taxpayers, who will ultimately foot the bill for reimbursement. According to one study, a full course of remdesivir treatment can be manufactured and sold with a 10% profit margin for about $9 – meaning that the price set by Gilead for health insurers is more than 350 times greater than the price necessary to produce and profit from the drug. Mintcafe 发表于 2020-07-17 01:02
这个都要骂， 他们两个活宝有没有问过病人？ 脑子里是不是除了收税， 最好什么都是免费的， 然后只剩下S了（忍不住骂脏话）。
Sens. Elizabeth Warren and Bernie Sanders slam Trump for giving Gilead ‘windfall’ deal for coronavirus drug
https://www.cnbc.com/2020/07/16/sens-elizabeth-warren-and-bernie-sanders-slam-trump-for-giving-gilead-windfall-deal-for-coronavirus-drug.html
。。。the deal will give Gilead up to $500 million in revenue borne almost entirely by American taxpayers, “in whole or in part” through higher insurance premiums.
“Outside analysts have concluded that ‘The deal is amazingly good for Gilead’s executives and shareholders and amazingly bad for everyone else—bad for taxpayers, terrible for public health, and unethical,’” the lawmakers wrote in the later dated Thursday. “We are therefore requesting information from the Department to help us better understand why President Trump—or whichever Administration officials were responsible— would strike such an expensive deal, and what steps the Administration is taking to ensure sufficient supply of the drug.” Gilead and HHS weren’t immediately available for comment.
The deal gives the U.S. more than 500,000 treatment courses of the antiviral drug for U.S. hospitals through September, the Department of Health and Human Services announced June 29. That represents 100% of Gilead’s projected production for July and 90% of production for August and September, according to the agency. Gilead said it would sell remdesivir for $520 per vial in the U.S. to patients with private insurance and $390 per vial to federal insurance programs like Medicare as well as foreign countries. The majority of patients treated with remdesivir receive a five-day treatment course using six vials of remdesivir, the company said. That would bring the cost to $2,340 for foreign and U.S. Medicare patients and $3,120 for U.S. patients with private health coverage.
不不不~那会儿他们俩就会想起来美国人优先这个事了哈哈哈哈~
Gilead has stated that governments of other developed countries will be paying $2,340 for a treatment course of remdesivir, but that American hospitals and other purchasers will be paying "approximately $3,200" – $860 more than the price in other countries. The higher prices charged by Gilead will result in higher insurance premiums for individuals and businesses that provide health insurance coverage. Although Medicare and Medicaid beneficiaries may be shielded from these higher costs, the costs of the drug will be borne by taxpayers, who will ultimately foot the bill for reimbursement. According to one study, a full course of remdesivir treatment can be manufactured and sold with a 10% profit margin for about $9 – meaning that the price set by Gilead for health insurers is more than 350 times greater than the price necessary to produce and profit from the drug.
这句话不是质问为什么美国卖到国内的反而比卖到国外的贵么？不是想办法减少美国人民的医疗负担么？
屎里几粒饭也是屎
这就是美国精彩的地方，前期政府大量拨款（税金），贩卖期合法合理的price gouging, 狂赚一票，结果是拉高保险，照旧还是我们的税金买单🤷♀️
Bernie的原文也看了啊，就一个意思：为毛卖这么贵，给个解释
跟American first一毛钱关系都没有
谢谢你 继续讨论。
不过这些媒体真是cherry pick， low ， 故意制造仇恨。。
第一， 原材料成本 远远不等于 最后售价， 因为有巨大前期研发费用， 和其他费用， 这个药物公司都是以亿， 几十亿来付出的。
第二， 其他国家价格低， 只讲最后价格， 不公平。
区域差别或者税收优惠很多因素都要全盘考虑等在里面，还有 有时出于人道主义， 降低margin， 也会卖。 最好的方法是不卖， 就永远没有问题了。
大家别忘了， 吉利德 公司早先已经无偿捐献了几十万试剂出来了。
两个活宝如果骂AMAZON 到算了， 但是吉利德这个公司， 还真是一个良心公司，但是人家不是活雷锋， 也要吃饭。 。
美帝医疗技术不用说 但是这个医保，发达国家里都算是垫底的，吐槽无力 Bernie质问一下价格问题，我都搞不懂楼里的某些人是怎么得出质疑“美国优先”的
SOS: The radical left socialists Sanders, Warren, AOC and Omar have hijacked the Biden campaign!
恐怕目的没有这么简单， 醉翁之意不在酒， 通篇都在暗示 Trump 政府和 Gilead 官商勾结， 然后如何如何。。。
作为一个资深的参议员， 因该有基本的经济常识， 或者有对应的团队来了解基本的商业运作手段和方式， 比如常规公司如何定价等等， 如何处理区域性价格差别等。。。因该是一个参议员office 副手就能够通过联系沟通 来了解的， 如果不行，在下一步动作。
现在呢，哈哈， 6个参议员一起上， 此地无银三百两。。。
这个题目太大了，要讨论几十页也不够啊，mm有兴趣去研究一下美国医药吧，为神马每五个人里就有一个无力负担处方药的，这是个极度畸形庞大，牵扯了无数利益的市场，就和楼上mm说的，医疗系统发达国家垫底，不是才怪呢，资本也要吃饭没错，但这个饭可不只为了吃饱，而且后果就是所有人的保险越来越高，越来越差。
你是对的， 这个题目衍生出来的话题很大。
就事论事， 我只是看不惯， 对一个关乎生命的药品， 看待和评论的它的价格时（不同国家， 对象， 不同时间，动态的问题）， 只看到数字，就6个参议员一起上，而不是 我一人看到， 我用民众赋予我的权利follow。
这里的政治目的太明显了，用来打击Trump 政府， 这几个人顶着为民做主的帽子， 塞私货。。。 不齿。
同意！ 照着民主党的建议，药厂都去当活雷锋了，看以后谁是傻子去开药厂研发新药救人。